PAR-20-092 - Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Special interest (NOSI): Medications Development for Stimulant Use Disorders NOT-DA-22-049 NIDA Dec 22, 2021 Sep 2, 2022 UG3/UH3


Technical Issues: E-mail OER Webmaster